Howe & Rusling Inc. Acquires 111 Shares of Cardinal Health, Inc. $CAH

Howe & Rusling Inc. increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 6.2% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,891 shares of the company’s stock after purchasing an additional 111 shares during the period. Howe & Rusling Inc.’s holdings in Cardinal Health were worth $261,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Pinnacle Bancorp Inc. boosted its stake in shares of Cardinal Health by 11.2% during the first quarter. Pinnacle Bancorp Inc. now owns 767 shares of the company’s stock valued at $106,000 after purchasing an additional 77 shares in the last quarter. Applied Finance Capital Management LLC boosted its stake in shares of Cardinal Health by 1.4% during the first quarter. Applied Finance Capital Management LLC now owns 6,049 shares of the company’s stock valued at $833,000 after purchasing an additional 85 shares in the last quarter. CSS LLC IL boosted its stake in shares of Cardinal Health by 0.8% during the fourth quarter. CSS LLC IL now owns 11,190 shares of the company’s stock valued at $1,323,000 after purchasing an additional 90 shares in the last quarter. Perigon Wealth Management LLC boosted its stake in shares of Cardinal Health by 4.2% during the first quarter. Perigon Wealth Management LLC now owns 2,242 shares of the company’s stock valued at $309,000 after purchasing an additional 90 shares in the last quarter. Finally, Jacobi Capital Management LLC boosted its stake in shares of Cardinal Health by 2.7% during the first quarter. Jacobi Capital Management LLC now owns 3,455 shares of the company’s stock valued at $476,000 after purchasing an additional 90 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on CAH. Jefferies Financial Group set a $150.00 price objective on shares of Cardinal Health in a research note on Tuesday, August 12th. Argus set a $189.00 target price on shares of Cardinal Health in a research note on Friday, August 22nd. Wells Fargo & Company restated an “overweight” rating and issued a $185.00 target price (up from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Wall Street Zen downgraded shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 2nd. Finally, Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Eleven analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $165.93.

Insiders Place Their Bets

In other Cardinal Health news, insider Michelle D. Greene sold 13,500 shares of the firm’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the transaction, the insider owned 14,976 shares of the company’s stock, valued at approximately $2,228,728.32. This trade represents a 47.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Jessica L. Mayer sold 38,078 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the transaction, the insider directly owned 48,457 shares of the company’s stock, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 271,676 shares of company stock valued at $40,489,525. Corporate insiders own 0.09% of the company’s stock.

Cardinal Health Trading Down 0.1%

NYSE CAH opened at $152.34 on Friday. The company has a fifty day simple moving average of $154.50 and a two-hundred day simple moving average of $147.65. The stock has a market cap of $36.38 billion, a P/E ratio of 23.62, a P/E/G ratio of 1.29 and a beta of 0.73. Cardinal Health, Inc. has a 12-month low of $106.54 and a 12-month high of $168.44.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The business had revenue of $60.16 billion during the quarter, compared to analysts’ expectations of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business’s quarterly revenue was up .5% on a year-over-year basis. During the same quarter last year, the company posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.63%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.